CAMBRIDGE, Mass.--(BUSINESS WIRE)--Idera Pharmaceuticals, Inc. (AMEX: IDP) today announced that Robert Karr, M.D., President of Idera, will discuss the Company’s Toll-Like Receptor - targeted drug discovery and development programs and provide a general corporate overview at the Canaccord Adams 27th Annual Global Growth Conference taking place August 7-9, 2007, in Boston, MA. The presentation will begin at 2:30 p.m. EDT on Wednesday, August 8, 2007.
